Zobrazeno 1 - 10 of 58 pro vyhledávání: '"Steven Canfield"'
3
Low testosterone and high cholesterol levels in relation to all-cause, cardiovascular disease, and cancer mortality in White, Black, and Hispanic men: NHANES 1988–2015
Autor: David S. Lopez, Wei-Chen Lee, Carlos Orellana Garcia, Paige Birkelbach Downer, Shaden Taha, Alejandro Villasante-Tezanos, Konstantinos K. Tsilidis, Kristen Peek, Markides Kyriakos, Steven Canfield
Publikováno v: Hormones. 21:399-411
The role of testosterone (T) deficiency (T ≤ 300 ng/dL) and hypercholesterolemia (total cholesterol ≥ 240 mg/dL) in the risk of all-cause cardiovascular diseases (CVD) and cancer mortality among a nationally representative sample of non-Hispanic
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66b264f39681c4123b11085fa4373b0d
https://doi.org/10.1007/s42000-022-00360-3
Zobrazit plný text záznamu
4
Akademický článek
Association of Urinary Phthalate Metabolites With Erectile Dysfunction in Racial and Ethnic Groups in the National Health and Nutrition Examination Survey 2001-2004
Autor: David S. Lopez DrPH, Shailesh Advani MPH, Konstantinos K. Tsilidis PhD, Run Wang MD, Jacques Baillargeon PhD, Adrian Dobs MD, Elaine Symanski PhD, Steven Canfield MD
Publikováno v: American Journal of Men's Health, Vol 11 (2017)
Phthalates are endocrine-disrupting compounds detectable in more than 75% of the U.S. population with differential distributions across racial and ethnic groups, and they have been linked with reduced levels of serum testosterone. This study aims to
Externí odkaz: https://doaj.org/article/581ee667edf84e98979bbb4d11c10d6c
Zobrazit plný text záznamu
5
Metformin and testosterone replacement therapy inversely associated with hormone-associated cancers (prostate, colorectal and male breast cancers) among older White and Black men
Autor: David S. Lopez, Ioannis Malagaris, Efstathia Polychronopoulou, Konstantinos K. Tsilidis, Sadaf A. Milani, M. Kristen Peek, Alejandro Villasante‐Tezanos, Laith Alzweri, Jacques Baillargeon, Yong‐Fang Kuo, Steven Canfield
Publikováno v: Clinical endocrinology. 97(6)
The independent and joint association of metformin and testosterone replacement therapy (TTh) with the incidence of prostate, colorectal, and male breast cancers remain poorly understood, including the investigation of the risk of these cancers combi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84f207c841c478f0f3fcafcf82c36578
https://pubmed.ncbi.nlm.nih.gov/35902376
Zobrazit plný text záznamu
8
Erythroblast transformation-specific transcription factor fusions in prostate cancer
Autor: Michelle Barbi de Moura, Fadel S. Alyaqoub, Gargi D. Basu, David W. Hall, Jess R Hoag, Janine R. LoBello, Frederick L. Baehner, Snehal Govind Thakkar, Steven Canfield
Publikováno v: Journal of Clinical Oncology. 41:224-224
224 Background: Common drivers in advanced prostate cancer (PC) involve fusions of the 3’ DNA binding domain-containing region of an Erythroblast Transformation Specific (ETS) transcription factor gene with a 5’ region of another gene, often one
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0f59598ff238347cbc3001d8acfd677b
https://doi.org/10.1200/jco.2023.41.6_suppl.224
Zobrazit plný text záznamu
9
Sequential enfortumab vedotin (EV) after platinum-based chemotherapy in metastatic or locally advanced urothelial cancer: Complete response, bladder preservation and survival
Autor: Putao Cen, Kok Hoe Chan, Steven Canfield, Tung Shu, Neha Maithel, Varaha Tammisetti
Publikováno v: Journal of Clinical Oncology. 41:529-529
529 Background: For metastatic or unresectable invasive urothelial cancer (UC), standard first-line platinum-based chemotherapy achieved progression-free survival (PFS) of 4–7 months. Complete response (CR) rate is
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8bcf26aafb2efb37863c8f05977c3769
https://doi.org/10.1200/jco.2023.41.6_suppl.529
Zobrazit plný text záznamu
10
Joint association of statins and testosterone replacement therapy with cardiovascular disease among older men with prostate cancer: SEER-Medicare 2007–2015
Autor: David S. Lopez, Hyunkyoung Kim, Efstathia Polychronopoulou, Shaden Taha, Konstantinos K. Tsilidis, Alejandro Villasante-Tezanos, M. Kristen Peek, Syed Gilani, Mohit Khera, Jacques Baillargeon, Yong-Fang Kuo, Steven Canfield
Publikováno v: Cancer Epidemiol
BACKGROUND: Use of statins and testosterone replacement therapy (TTh) have been independently linked with prostate cancer (PCa) and cardiovascular diseases (CVD). However, there is a research gap about the joint association of statins and TTh with CV
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::770049f8bc461896474adfa1a437ceee
https://doi.org/10.1016/j.canep.2022.102172
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje